IVOB in Breakout Mode! INVO Bioscience, Inc. (INVO Bioscience) is a development-stage company. The Company is engaged in the development of technology for the treatment of infertility. Its device, the INVOcell, and the INVO procedure are designed to provide an alternative, low cost infertility treatment for the patient and the clinician. INVO also allows conception and embryo development to take place inside the woman's body.
The INCOcell is approved for use in numerous other countries, and is close to approval in the United States. 10B Invetro Market. FDA response expected any day now.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.